BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, today announced CE approval and the results of a pilot study into the performance of BioMonitor 2.

In the 40 years between 1970-2010, the proportion of patients with diabetes undergoing coronary artery bypass grafting (CABG) escalated from 7% to 37%. The results of a large study from Cleveland Clinic just published in The Journal of Thoracic and Cardiovascular Surgery, the official publication of the American Association for Thoracic Surgery (AATS), documents the five-fold increase in the proportion of patients with diabetes undergoing this procedure between 1970 and 2010. 

Colibri Heart Valve LLC, a privately held emerging medical device company, has received an Issue Notification from the U.S. Patent and Trademark Office regarding the forthcoming granting of its "Percutaneous Replacement Heart Valve and a Delivery and Implantation System." 

The American College of Cardiology is collaborating with Apollo Hospitals in India to provide the College’s guideline-driven educational content to physicians participating in Apollo’s Medvarsity e-learning program, India’s first medical e-learning venture.

Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, announced it will file a submission today with the U.S. Food and Drug Administration (FDA) for 510(k) clearance to market its Pantheris image-guided atherectomy device for the treatment of patients with peripheral arterial disease (PAD).

The Society of Cardiovascular Computed Tomography (SCCT) announces the recipients of the 2015 Arthur S. Agatston Cardiovascular Disease Prevention Awards, which were recently presented at the 10th Annual Scientific Meeting (SCCT2015), held in Las Vegas, Nevada. 

Medtronic plc (NYSE: MDT) today announced the launch of its Entrust(TM) delivery system in the United States. The new Entrust delivery system enables physicians to place Medtronic's EverFlex(TM) self-expanding peripheral stent, while maintaining a low profile and providing the ease of a one-handed device.

TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the U.S. Food and Drug Administration (FDA) approved the Ovation iX Abdominal Stent Graft System. Delivery system enhancements of Ovation iX, which stands for integrated exchange, are designed to provide physicians with additional flexibility for even more predictable deployment and greater ease of use.